On March 20, the Shanghai Stock Exchange officially accepted the IPO application from Unitree Robotics for listing on the Science and Technology Innovation Board, with plans to raise an estimated 4.202 billion yuan. This move positions Unitree Robotics to potentially become the inaugural "humanoid robot stock" on the A-share market. Presently, embodied AI firms are intensifying their financing endeavors and progressing steadily toward public listing. Data indicates that since March, the domestic embodied AI sector has witnessed 40 investment and financing events, marking a year-on-year doubling. A steady stream of companies, each valued in the billions of yuan, has emerged. This investment and financing surge has catalyzed the approach of an IPO inflection point, with several entities, including Deep Robotics, also expediting their public listing preparations.

Embodied AI companies are concurrently prioritizing both mass production and R&D initiatives. The broadening of commercial applications has laid the groundwork for the large-scale production of humanoid robots, a process that demands significant financial backing. Simultaneously, these firms are achieving ongoing technological advancements in pivotal areas such as robot intelligence and data acquisition, necessitating substantial R&D investments.